VA106483 Dose Response in Females
NCT01171391
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
21
Enrollment
INDUSTRY
Sponsor class
Conditions
Nocturia
Interventions
DRUG:
VA106483
OTHER:
Placebo
Sponsor
Vantia Ltd